Robert Hromas Selected Research

Chemokine CCL21

1/2021	A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease.
8/2002	The chemokine CCL21 protects normal marrow progenitors from Ara-C cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Hromas Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 10/2005
5	Leukemia 11/2021 - 08/2002
5	Genetic Translocation (Chromosomal Translocation) 01/2019 - 07/2010
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2009
3	Genomic Instability 01/2021 - 01/2011
3	Infections 01/2021 - 12/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2012
2	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 01/2019
2	Glioma (Gliomas) 12/2021 - 01/2019
2	Fanconi Anemia (Fanconi's Anemia) 12/2020 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2005 - 10/2005
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Ulcerative Colitis 01/2021
1	Celiac Disease (Celiac Sprue) 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 12/2019
1	Thrombocytopenia (Thrombopenia) 12/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Bone Marrow Failure Disorders 01/2019
1	Malignant Mesothelioma 10/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Colonic Neoplasms (Colon Cancer) 07/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2013
1	Ovarian Neoplasms (Ovarian Cancer) 06/2011

Drug/Important Bio-Agent (IBA)

14	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2005
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2011
4	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 08/2021 - 03/2014
3	Proteolysis Targeting ChimeraIBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 12/2021 - 01/2011
3	Antineoplastic Agents (Antineoplastics)IBA 12/2019 - 01/2011
2	Biological ProductsIBA 01/2022 - 01/2019
2	DT2216IBA 01/2022 - 12/2019
2	snake venom protein C activatorIBA 01/2022 - 12/2019
2	Histones (Histone)IBA 01/2022 - 01/2011
2	navitoclaxIBA 12/2021 - 12/2019
2	ChemokinesIBA 01/2021 - 08/2006
2	Chemokine CCL21IBA 01/2021 - 08/2002
2	Poly (ADP-Ribose) Polymerase-1IBA 01/2019 - 05/2013
2	EndonucleasesIBA 11/2017 - 03/2014
2	A-Form DNA (A-DNA)IBA 05/2013 - 06/2011
2	TransposasesIBA 07/2010 - 05/2010
2	trioctyl phosphine oxide (TOPO)IBA 01/2009 - 10/2008
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	carbazoleIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	olaparibIBA 01/2022
1	talazoparibIBA 01/2022
1	RNA Demethylase AlkB Homolog 5IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	UbiquitinIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Annexin A5IBA 01/2022
1	6-methyladenineIBA 01/2022
1	CrizotinibIBA 12/2021
1	Neutralizing AntibodiesIBA 12/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Fanconi Anemia Complementation Group D2 ProteinIBA 12/2020
1	Discoidin Domain ReceptorsIBA 06/2020
1	Ligases (Synthetase)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Protons (Proton)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	CarbonIBA 01/2019
1	IonsIBA 01/2019
1	Proto-Oncogene Proteins c-metIBA 01/2019
1	Complementary DNA (cDNA)IBA 11/2017
1	AICA ribonucleotide (ZMP)IBA 01/2016
1	Phosphates (Orthophosphate)IBA 01/2016
1	Adenosine (Adenocard)FDA LinkGeneric 01/2016
1	RibonucleotidesIBA 01/2016
1	Temozolomide (Temodar)FDA LinkGeneric 01/2015
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2015
1	NSC666715IBA 01/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2014
1	SmokeIBA 04/2013
1	QuinolonesIBA 12/2012
1	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2012
1	PlatinumIBA 02/2012
1	TitaniumIBA 02/2012
1	MetalsIBA 02/2012
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2011
1	neoamphimedineIBA 01/2011
1	Topoisomerase InhibitorsIBA 05/2010
1	Transcription Factors (Transcription Factor)IBA 07/2009
1	AnthracyclinesIBA 01/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2009

Therapy/Procedure

12	Therapeutics 01/2022 - 08/2002
9	Drug Therapy (Chemotherapy) 01/2022 - 10/2005
5	Radiotherapy 12/2021 - 10/2017
1	Immunotherapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2009